Acceleron Pharma to Host Second Quarter 2015 Financial Results Conference Call and Webcast on August 6, 2015

CAMBRIDGE, Mass.--()--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today announced that the Company will host a conference call and live webcast on Thursday, August 6, 2015, at 8:00 AM (EDT) to report second quarter 2015 financial results and provide a corporate update.

To participate by teleconference, please dial 877-312-5848 (domestic) or 253-237-1155 (international) and refer to the Acceleron Q2 Earnings Call. To access the live webcast, please select “Events & Presentations” in the Investors & Media section on the Company’s website (www.acceleronpharma.com) at least 10 minutes beforehand to ensure time for any downloads that may be required.

An archived webcast recording will be available on the Acceleron website beginning approximately two hours after the event.

About Acceleron

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair. The company is a leader in understanding the biology of the Transforming Growth Factor-Beta (TGF-β) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body, and in targeting these pathways to develop important new medicines. Acceleron has built a highly productive R&D platform that has generated innovative clinical and preclinical protein therapeutic candidates with novel mechanisms of action. These protein therapeutic candidates have the potential to significantly improve clinical outcomes for patients with cancer and rare diseases.

For more information, please visit www.acceleronpharma.com.

Contacts

Acceleron Pharma
Kevin F. McLaughlin, 617-649-9204
Senior Vice President and Chief Financial Officer
or
Media Contact:
Suda Communications LLC
Maureen L. Suda, 585-387-9248

Release Summary

Acceleron to host a conference call and live webcast on Thursday, August 6, 2015, at 8:00 AM (EDT) to report 2Q 2015 financial results and provide a corporate update.

Contacts

Acceleron Pharma
Kevin F. McLaughlin, 617-649-9204
Senior Vice President and Chief Financial Officer
or
Media Contact:
Suda Communications LLC
Maureen L. Suda, 585-387-9248